Genotype-to-drug
Explore how selected genetic variants may influence the response to particular medications.
Research focus 03
Pharmacogenomics
research.
Research into how genetic variation influences medication response—supporting the scientific foundation of more personalized, effective and safer treatment.
Why it matters
The right evidence
for a more precise therapy.
People can respond differently to the same medication. Pharmacogenomics investigates whether inherited genetic differences help explain variation in drug efficacy, metabolism and adverse effects.
Research services
Two directions.
One evidence base.
Drug-to-genotype
Start with a medication and examine genes and variants reported to affect efficacy, exposure or safety.
Regulatory evidence
Review pharmacogenomic associations reflected in regulatory labeling and authoritative guidance.
Broader evidence
Consider well-supported associations beyond regulatory lists while clearly distinguishing evidence levels.
Responsible use
Evidence interpreted
in context.
Pharmacogenomic information is one part of clinical decision-making. Medication changes should be made only by qualified healthcare professionals who can consider the full clinical picture.
Connect with Genet
Bring your expertise.
Start a conversation.
Talk to us about research, partnerships or our advisory network.